Country primarily held responsible for gain-of-function research leading to COVID-19 by end of 2025?
United States • 25%
China • 25%
Both equally • 25%
Neither • 25%
International or national government reports and statements
Congressional Report: COVID-19 Likely Originated from US-Funded Gain-of-Function Research in Wuhan Lab
Dec 2, 2024, 06:45 PM
A two-year congressional investigation has concluded that the COVID-19 pandemic most likely originated from a lab leak at a Wuhan laboratory in China. The lab was reportedly conducting gain-of-function research on bat coronaviruses, funded in part by the U.S. National Institutes of Health (NIH) until 2022. The investigation highlights that U.S. taxpayers indirectly financed this research, which involved intentionally manipulating viruses. The report also alleges efforts by key figures, including Anthony Fauci, to suppress information and obstruct investigations into the origins of COVID-19. It further notes that the research was subcontracted to China to bypass an Obama-era moratorium on gain-of-function studies.
View original story
NIH • 25%
Wuhan Institute of Virology • 25%
No specific accountability • 25%
EcoHealth Alliance • 25%
Laboratory data • 25%
Other • 25%
Animal market data • 25%
Environmental samples • 25%
Other • 25%
WHO • 25%
European Union • 25%
United States • 25%
United States • 25%
United Kingdom • 25%
Other • 25%
Australia • 25%
Supports lab origin • 25%
Inconclusive • 25%
Supports natural origin • 25%
No new findings • 25%
China • 25%
United States • 25%
Both • 25%
Neither • 25%
China • 25%
Russia • 25%
Other/None Identified • 25%
Cuba • 25%
No new significant findings • 25%
Further research required • 25%
New evidence supports natural origin • 25%
New evidence supports lab origin • 25%
No definitive conclusion • 25%
Refutes lab leak • 25%
Confirms lab leak • 25%
Calls for more research • 25%
Natural origin • 33%
Lab origin • 33%
Inconclusive • 34%
Department of Justice • 25%
No action taken • 25%
Congress • 25%
State Attorney General • 25%
Neutral • 25%
Critical • 25%
Mixed reactions • 25%
Supportive • 25%
No significant action • 25%
Diplomatic actions against China • 25%
New regulations on research funding • 25%
Public inquiry or hearings • 25%